The stock of Mediclinic International PLC (LON:MDC) reached all time low today, Nov, 24 and still has GBX 665.95 target or 8.00% below today’s GBX 723.86 share price. This indicates more downside for the GBX 5.34 billion company. This technical setup was reported by Barchart.com. If the GBX 665.95 PT is reached, the company will be worth GBX 427.20 million less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only. The stock decreased 0.75% or GBX 5.44 on November 24, hitting GBX 723.86. About 1.11 million shares traded hands. Mediclinic International PLC (LON:MDC) has declined 19.28% since April 27, 2016 and is downtrending. It has underperformed by 24.69% the S&P500.
Mediclinic International PLC (LON:MDC) Ratings Coverage
Out of 10 analysts covering Mediclinic International (LON:MDC), 3 rate it a “Buy”, 1 “Sell”, while 6 “Hold”. This means 30% are positive. Mediclinic International has been the topic of 18 analyst reports since February 18, 2016 according to StockzIntelligence Inc. The firm has “Buy” rating by Investec given on Monday, May 9. The company was upgraded on Tuesday, June 28 by Citigroup. The firm has “Neutral” rating given on Monday, September 12 by Citigroup. UBS maintained Mediclinic International PLC (LON:MDC) on Tuesday, September 6 with “Buy” rating. Macquarie Research maintained Mediclinic International PLC (LON:MDC) rating on Wednesday, November 23. Macquarie Research has “Neutral” rating and GBX 830 price target. As per Thursday, February 18, the company rating was maintained by Citigroup. The stock of Mediclinic International PLC (LON:MDC) earned “Buy” rating by UBS on Monday, November 21. JP Morgan maintained the shares of MDC in a report on Tuesday, August 23 with “Neutral” rating. On Friday, November 11 the stock rating was maintained by Credit Suisse with “Outperform”. The rating was maintained by Citigroup on Tuesday, May 24 with “Neutral”.
Mediclinic International plc, formerly Al Noor Hospitals Group plc, is a holding company. The company has a market cap of 5.34 billion GBP. The Firm operates as an international private healthcare provider. It has a 26.46 P/E ratio. The Company’s divisions include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.